Myriad Genetics Inc 10-Q, filed Feb 7, 2020
Myriad Genetics Inc (MYGN)
10-Q
2020-02-07
For: 2019-12-31
View Original
Added on
April 12, 2026
About this 10-Q
Myriad Genetics Inc filed this 10-Q on February 7, 2020, covering the quarter ended December 31, 2019.
Headline figures
Quarter ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $195.1M
- down 10.0% from $216.8M a year earlier
- Net loss
- $8.3M
- compared with net income of $2.6M a year earlier
- Diluted EPS
- -$0.11
- compared with $0.03 a year earlier